Digestive Disease Week® (DDW) 2025 is almost here — make sure to add these sessions to your calendar and get the latest updates on essential practice management issues and emerging technologies. View these and more sessions in the DDW Meeting Planner. If you haven’t already, don’t forget to register for DDW — rates increase May 1.
Author: Abhay Panchal
With 30% of the population already affected and projections soaring to 41.4% by 2050, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is rapidly emerging as the silent giant of modern chronic disease. More than a liver issue, MASLD is now seen as a complex metabolic disease requiring collaboration across hepatology, endocrinology, primary care, nutrition, and more. Harvard’s Dr. Christos Mantzoros says: “We don’t have enough experts to treat these patients… We need collaboration, training, and professional societies building bridges.”
The average monthly gastroenterology case volume at ASCs in 2024 reached 176, up from 167 in 2023, according to HST Pathways’ latest “State of the Industry Report.“The report surveyed 590 ASCs in 47 states.Here are five more key insights
In this episode, Venture Science founding partner Matt Oguz sits down with the founder & CEO of Jona, a trailblazing company unlocking the secrets of the microbiome to drive personalized health insights. Explore how gut health is rapidly becoming central to preventative medicine, and how microbiome diagnostics are shedding new light on chronic conditions like: You’ll also learn how Jona is turning complex microbiome data into actionable guidance—and why this matters for the future of health and wellness.
Medscape Gastroenterologists and Suicide Report 2025: Key Takeaways
A new randomized clinical trial published in JAMA Network Open shows that a mailed fecal immunochemical test (FIT) outreach program significantly increased colorectal cancer (CRC) screening among Medicaid enrollees in rural areas, compared to usual care. Key Findings:
The Trump administration has initiated mass layoffs across major U.S. health agencies, cutting 10,000 jobs as part of a broader government downsizing effort led by HHS Secretary Robert F. Kennedy Jr. and Elon Musk. Agencies affected include the FDA, CDC, and NIH, with reports of security guards informing staff of their terminations as they arrived at work.
This article explores how electronic health records (EHRs), while beneficial for data access and care coordination, contribute significantly to provider burnout in inflammatory bowel disease (IBD) care. Tasks like documentation, chart review, and in-basket messaging consume excessive time, especially for IBD specialists. Despite prior efforts—including standardized templates, order sets, and collaborative networks like IBD Qorus and ImproveCareNow—barriers persist due to varying platforms and lack of standardization.
A new bipartisan bill, the Reducing Medically Unnecessary Delays in Care Act, aims to reform prior authorization in Medicare by requiring that only board-certified physicians in the same specialty review and approve care requests. The bill seeks to reduce treatment delays, ensure medical necessity is determined by experts, and increase transparency by mandating that clinical criteria be published and evidence-based. Backed by major medical associations, the bill responds to growing concerns that non-specialists are delaying or denying necessary care, contributing to poor outcomes and physician burnout.
The FDA has approved the Rectal Expulsion Device (RED), developed at the University of Michigan by Drs. Eric Shah and William Chey, to help diagnose and guide treatment for chronic constipation. RED uses a simple tube and balloon to identify pelvic floor dysfunction during a primary care visit, helping patients avoid unnecessary referrals and ineffective laxatives.